Questions? +1 (202) 335-3939 Login
Trusted News Since 1995
A service for global professionals · Thursday, March 28, 2024 · 699,471,009 Articles · 3+ Million Readers

Global Topical Drug Delivery Trends and Forecasts to 2024 with Galderma Pharma Set to Dominate

Dublin, Oct. 19, 2017 (GLOBE NEWSWIRE) -- The "Global Topical Drug Delivery Analysis, Companies Profiles, Size, Share, Growth, Trends and Forecast to 2024" report has been added to Research and Markets' offering.

Global topical drug delivery market is expected to reach USD 205.1 billion by 2024 from USD 101.7 billion in 2016, growing at a CAGR of 9.2% in the forecast period 2017 to 2024.

Scope of the Report

  • On the basis of product type the market is segmented into transdermal drug delivery devices and topical drug delivery formulations.
  • Topical drug delivery formulations are further segmented based on form into solid, semi-solid and liquid. The semi solid segment is further classified into ointments, creams, lotions, gels and pastes. The solid drugs segment is further segmented into powders and suppositories.
  • The liquid drugs segment is further classified into solutions and suspensions. The transdermal drug delivery devices market segment is further segmented into patches and gels.
  • The topical drug delivery market is segmented on the basis of indications into 4 types such as acne, anesthetics, psoriasis, dermatitis & atopic dermatitis, rosacea, onychomycosis, alopecia, actinic keratosis, and others.
  • On the basis of end users the market is segmented into hospitals, home healthcare, clinics, diagnostic centers, and others.

Market Dynamics

Drivers

  • Rising Cases of Acute and Chronic Disease
  • Rising Aging Population
  • Technological Advancements and Innovations
  • Approval of New Drugs
  • Better Opportunity in Pharmerging Markets

Restraints

  • Regulatory Scenario and Pricing Pressure

Opportunity

  • Emerging Market
  • Rising Acceptance for Self-Administration of Drugs

Challenges

  • Product Recall
  • Penetration into the Smaller Markets

Galderma Pharma, S.A., dominated the topical drug delivery market accounting for a highest market share in 2016, followed by Bayer AG, and Valeant Pharmaceuticals.

  • MedPharm, Janssen Pharmaceuticals, Inc. (A J&J Company)
  • Crescita Therapeutics
  • West Pharmaceutical Services
  • Biofarmitalia s.r.l
  • Pharmatek Laboratories, Inc.
  • Stiefel Laboratories, Inc.
  • Tapemark, Acrux Limited
  • Nitto Denko Corporation
  • Skinvisible Pharmaceuticals, Inc.
  • Mylan Pharmaceuticals Inc.
  • Pocono Coated Products LLC
  • TheraSolve NV.
  • Samyang Biopharmaceuticals Corporation
  • Lohmann Therapie-Systeme AG
  • Prosollus Pharmaceuticals
  • Easton Pharmaceuticals Inc.
  • Novosis AG
  • Endo Pharmaceuticals Inc.
  • Transdermal Technologies, Inc.
  • Sheffield Pharmaceuticals, Inc.
  • Solvay

Key Topics Covered:

1. Introduction

2. Market Segmentation

3. Market Overview

4. Premium Insights

5. Executive Summary

6. Global Topical Drug Delivery Market, by Type

7. Global Topical Drug Delivery Market, by Indication

8. Global Topical Drug Delivery Market, by Distribution Channel

9. Global Topical Drug Delivery Market, by End User

10. Global Topical Drug Delivery Market, by Geography

11. Global Topical Drug Delivery Market, Company Share

12. Company Profiles

For more information about this report visit https://www.researchandmarkets.com/research/4pbdbl/global_topical


                    
                    
                    CONTACT: Research and Markets
                             Laura Wood, Senior Manager
                             press@researchandmarkets.com
                             For E.S.T Office Hours Call 1-917-300-0470
                             For U.S./CAN Toll Free Call 1-800-526-8630
                             For GMT Office Hours Call +353-1-416-8900
                             Related Topics: Drug Delivery
                    

Primary Logo

Powered by EIN News


EIN Presswire does not exercise editorial control over third-party content provided, uploaded, published, or distributed by users of EIN Presswire. We are a distributor, not a publisher, of 3rd party content. Such content may contain the views, opinions, statements, offers, and other material of the respective users, suppliers, participants, or authors.

Submit your press release